论文部分内容阅读
目的:研究非索非那定联合雷公藤多甙对慢性荨麻疹患者的疗效。方法抽取我院慢性荨麻疹患者136例分为联用药组和单用药组,单用药组应用口服非索非那定,联用药组在单用药组治疗基础上增加使用雷公藤多甙。对比疗效和安全性。结果联用药组总有效显著高于单用药组(<0.05)。联用药组和单用药组不良反应发生情况无统计学差异(>0.05)。结论应用雷公藤多甙联合咪唑斯汀治疗慢性荨麻疹,临床效果显著,不良反应低,可以在临床治疗中应用。“,”Objective Fexofenadine Tripterygium glycosides combined ef ect of chronic urticaria patients. Methods Extracting our hospital 136 cases of chronic urticaria patients into treatment group and single drug-linked group, single drug group received oral fexofenadine, linking the treatment group increased use of Tripterygium glycosides in the treatment group on the basis of a single drug. Comparative ef icacy and safety. Results Linking the total ef ective treatment group was significantly higher than single-drug group ( <0.05). Associated adverse drug group and single drug group ef ects were not statistical y significant ( ﹥ 0.05). Conclusion Tripterygium glycosides joint Mizolastine treatment of chronic urticaria, significant clinical ef ect, low adverse reactions, can be used in clinical treatment.